Showing 20 of 123 recruiting trials for “Systemic lupus erythematosus”
RecruitingNCT07313475 ↗
Evaluation of the Cryocheck HexLA Integrated TCA for the Detection of Lupus Anticoagulant
RecruitingNCT06796569 ↗
Systemic Immune Inflammatory Index in Systemic Lupus Erythematosus
A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease
Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus
An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE).
Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial
RecruitingNCT06642870 ↗
Rare AutoImmune SElf-management Programme Development
RecruitingNCT06804057 ↗
CorEvitas Systemic Lupus Erythematosus (SLE) Drug Safety and Effectiveness Registry
Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
Clinical Study of A-319 in the Treatment of Active/Refractory Systemic Lupus Erythematosus
👨⚕️ Qiubai Li, Professor, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology📍 2 sites📅 Started Jul 2024View details ↗
Integration of Remote Monitoring in the Management of Chronic Immunosuppressive Therapy
Intervention to Improve Communication and Medication Adherence in Lupus
A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
RecruitingNCT06491602 ↗
A Study of Clinical Characteristics ,Risk Factors and Outcome of Lupus Nephritis Among Children With Systemic Lupus Erthromatousus in Sohag Univeristy Hospital
A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →